SCHEMBL22909710

SCHEMBL22909710

Cc1cc(-n2nc3c(c2N)[C@H](C)N(C(O)OC(C)(C)C)CC3)ccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21183670 0.80 THRB (0.37) —
SCHEMBL21175390 0.77 ENPP2 (0.35) —
SCHEMBL26765656 0.75 GLP1R (0.50) —
SCHEMBL20014821 0.69 NR1H2 (0.33) —
SCHEMBL28952435 0.69 NR1H2 (0.33) —
SCHEMBL26765530 0.68 GLP1R (0.49) —
SCHEMBL20015371 0.68 F12 (0.50) —
SCHEMBL29475107 0.68 F12 (0.50) —
SCHEMBL26765456 0.67 GLP1R (0.50) —
SCHEMBL26765592 0.67 GLP1R (0.51) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210017176-A1 PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2021-01-21 — — US disclosed
Send feedback